When we applied the algorithm in each of the tumor samples, we found a set of signatures that were changing in a remarkably continuous manner across the samples, some of them being very similar to those of the normal samples, while others are similar to the COL11A1-based signature. The gene discussed is COL11A1; the disease is neoplasm.